Synthesis of Bioactive Diterpenoids from the ent-Kaur-16-en-19- oic Acid
Închide
Articolul precedent
Articolul urmator
82 0
SM ISO690:2012
UNGUR, Nikon, MORĂRESCU (CHETRARU), Olga, GRINCO, Marina, KULCIŢKI, Veaceslav, GUDUMAK, V., GULYA, Aurelian. Synthesis of Bioactive Diterpenoids from the ent-Kaur-16-en-19- oic Acid. In: French-Romanian Colloquium on Medicinal Chemistry, Ed. 4, 5-7 octombrie 2017, Iași. Iași : “Alexandru Ioan Cuza” University of Iasi, 2017, Ediţia 4, p. 75.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
French-Romanian Colloquium on Medicinal Chemistry
Ediţia 4, 2017
Colocviul "4th French-Romanian Colloquium on Medicinal Chemistry"
4, Iași, Romania, 5-7 octombrie 2017

Synthesis of Bioactive Diterpenoids from the ent-Kaur-16-en-19- oic Acid


Pag. 75-75

Ungur Nikon1, Morărescu (Chetraru) Olga1, Grinco Marina1, Kulciţki Veaceslav1, Gudumak V.2, Gulya Aurelian3
 
1 Institute of Chemistry of the Academy of Sciences of Moldova,
2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
3 Moldova State University
 
 
Disponibil în IBN: 18 aprilie 2024


Rezumat

The ent-kaur-16-en-19-oic acid (1) was isolated from different vegetal sources, especially from sunflower (Helianthus sp). [1]. We have described isolation of acid (1) from the integral sunflower (Helianthus annuus L.) dry wastes [2-3]. The scientific interest for tetracyclic diterpenic ent-kaur-16-en-19-oic acid (1) and its derivatives can be explained by their broad spectrum of biological activities [4-6]. We report in the current communication a series of chemical transformations leading to additional functionalization at exo-methylenic double bond of (1). The synthesized diterpenic compounds (2) – (5) have been identified on comparison of their spectroscopic data (IR, 1H- and 13C-NMR) with those given in the literature. The structure and stereochemistry of the new compound (6) was established on the basis of the spectral data. Preliminary investigation of the biological activity profile of diterpenic acids (3), (4) and (6) showed a selective inhibition of HELA BxPc-3, RD tumor cells.